Mitozolomide in advanced renal cancer. A phase II study in previously untreated patients from the EORTC Genito-Urinary Tract Cancer Cooperative Group

Eur J Cancer Clin Oncol. 1989 Aug;25(8):1249-50. doi: 10.1016/0277-5379(89)90422-7.
No abstract available

MeSH terms

  • Adult
  • Aged
  • Antineoplastic Agents / adverse effects
  • Antineoplastic Agents / therapeutic use*
  • Bone Marrow / drug effects
  • Carcinoma, Renal Cell / drug therapy*
  • Drug Evaluation
  • Female
  • Humans
  • Kidney Neoplasms / drug therapy*
  • Male
  • Middle Aged
  • Nitrogen Mustard Compounds / adverse effects
  • Nitrogen Mustard Compounds / therapeutic use*

Substances

  • Antineoplastic Agents
  • Nitrogen Mustard Compounds
  • mitozolomide